how many americans are on a glp 1 GLP-1 Use Has More Than Quadrupled Since 2021 as Obesity Rates Continue to Show Signs of Decline The GLP-1 Capitals: Where Weight

In April 2026, the FDA listed BPC-157-related and TB-500-related bulk drug substances for Pharmacy Compounding Advisory Committee discussion on July 23, 2026, regarding possible inclusion on the 503A Bulks List

THESE PRODUCTS ARE NOT INTENDED TO DIAGNOSE, TREAT, CURE, OR PREVENT ANY DISEASE

For patients with mild skin laxity, non-surgical treatments like radiofrequency, Thermage, for example, or ultrasound skin tightening will help somewhat

Nail disorders account for 10% of dermatologic disorders

Carnitine regulatory abnormalities have been attributed to diabetic complications, trauma, hemodialysis, starvation, obesity, cardiomyopathy, fasting, endocrine imbalances, medication interactions, and other conditions (Guerra et al